Advances in Clinical Chemistry, Volume 81, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. New to this latest release are chapters that cover Microparticles in Chronic Heart Failure, Peptide Antibodies in Clinical Laboratory Diagnostics, Measurement and Clinical Utility of ßCTX in Serum and Plasma, Human Papillomavirus and its Testing Assays, Cervical Cancer Screening, and Vaccination, and Physical Exercise and DNA Injury: Good or Evil? The serial presents the latest technologies related to the field of clinical chemistry, and is the benchmark for novel analytical approaches in the clinical laboratory.
Series edited by:
Gregory S. Makowski (Vice President and Chief Scientific Officer Clinical Laboratory Partners Newington CT USA),
Gregory S. Makowski (Clinical Laboratory Partners,
Newington; Hartford Hospital,
Hartford; Department of Laboratory Medicine,
University of Connecticut Health Center,
Farmington,
CT,
USA),
Gregory S. Makowski (Clinical Laboratory Partners,
Newington; Hartford Hospital,
Hartford; Department of Laboratory Medicine,
University of Connecticut Health Center,
Farmington,
CT,
USA),
Gregory S. Makowski (Clinical Laboratory Partners,
Newington; Hartford Hospital,
Hartford; Department of Laboratory Medicine,
University of Connecticut Health Center,
Farmington,
CT,
USA),
Gregory S. Makowski (Clinical Laboratory Partners,
Newington; Hartford Hospital,
Hartford; Department of Laboratory Medicine,
University of Connecticut Health Center,
Farmington,
CT,
USA)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions:
Height: 229mm,
Width: 152mm,
Weight: 630g
ISBN: 9780128120743
ISBN 10: 0128120746
Series: Advances in Clinical Chemistry
Pages: 296
Publication Date: 20 June 2017
Audience:
Professional and scholarly
,
Undergraduate
Format: Hardback
Publisher's Status: Active
1. Microparticles in Chronic Heart FailureA.E. Berezin2. Peptide Antibodies in Clinical Laboratory DiagnosticsN.H. Trier and G. Houen3. Measurement and Clinical Utility of ßCTX in Serum and PlasmaS.A.P. Chubb and S.D. Vasikaran4. Human Papillomavirus and its Testing Assays, Cervical Cancer Screening, and VaccinationY. Zhu, Y. Wang, J. Hirschhorn, K.J. Welsh, Z. Zhao, M.R. Davis and S. Feldman5. Physical Exercise and DNA Injury: Good or Evil?E. Danese, G. Lippi, F. Sanchis-Gomar, G. Brocco, M. Rizzo, M. Banach and M. Montagnana6. Bulky DNA Adducts, Tobacco Smoking, Genetic Susceptibility and Lung Cancer RiskA. Munnia, R.W. Giese, S. Polvani, A. Galli, F. Cellai and M.E.M. Peluso
Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.